Hydrophilic HASA-Gel Matrix for Localized Homeopathic Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current homeopathic remedies, particularly topical formulations, often have limited effectiveness for severe ailments and injuries due to their low potency and inability to be directly administered to specific locations on the body, leading to suboptimal treatment of localized issues.
Innovation Solution
A method of producing a hydrophilic homeopathic aqueous substance active (HASA)-gel matrix by combining a homeopathic compound with an uninhibited aqueous composition and a hydrophilic gelling agent, using thickening, crosslinking, or polymerization agents to create a therapeutically effective gel that can be applied topically, with potencies ranging from at least 6X to 10^-4 dilution factors, allowing for prolonged contact with biological tissues to enhance treatment efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If homeopathic remedies are formulated as topical gels with low potencies, then they can be directly administered to the site of ailment, but they have limited effectiveness for severe ailments and injuries
Solution Approach 1:
The patent applies parameter changes by formulating topical gels with medium to high potency homeopathic compounds (greater than 30C, such as 200C, 1M, 10M, and 50M), moving beyond the conventional low potency formulations. This changes the concentration parameter of the active ingredient to achieve greater therapeutic effectiveness for severe ailments while maintaining topical applicability
Solution Approach 2:
The patent creates composite materials by combining homeopathic compounds with gel bases to form topical gel formulations. This composite structure allows the integration of high potency homeopathic agents into a topical delivery system, enabling both direct application to the site of injury and enhanced therapeutic effect
2Ease of operation
If homeopathic remedies are administered orally, then they can treat systemic diseases, but they cannot be directly administered to localized ailments and therapy is limited to less than 20 minutes
Solution Approach 1:
The patent employs gel formulations that can be applied as flexible topical preparations directly to the site of injury. The gel matrix allows the homeopathic compound to remain in contact with the affected area, providing extended localized therapy rather than the brief oral administration window
Solution Approach 2:
The gel base acts as an intermediary carrier that delivers the homeopathic compound directly to the site of injury. This intermediary medium enables prolonged contact between the active ingredient and the affected tissue, extending the duration of therapeutic action beyond the limitations of oral administration
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hydrophilic HASA-gel matrix provides sustained therapeutic effects by maintaining the homeopathic compound in an aqueous environment, increasing the duration of treatment and enhancing the delivery of active ingredients to specific sites, thereby improving the treatment of localized injuries and ailments without the need for surgical intervention.
Implementation Method 1
combining the HASA with at least one hydrophilic gelling agent; and (c) thereafter, forming the hydrophilic HASA-gel matrix
Data Source
AI summary
Methods of producing a Hydrophilic Homeopathic Aqueous Substance Active (HASA)-gel matrix, include the steps of: (a) combining a homeopathic compound and an uninhibited aqueous composition to produce a HASA; (b) combining the HASA with at least one hydrophilic gelling agent; and (c) thereafter, forming the hydrophilic HASA-gel matrix by use of at least one of a thickening agent, a crosslinking agent, or a polymerization agent.